Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarepta
Sarepta
Sarepta And Eteplirsen: Will 12 Patients Be Enough For The FDA?
Seeking Alpha
Wed, 06/19/13 - 10:33 am
Sarepta
eteplirsen
FDA
GSK
Duchenne Muscular Dystrophy
3 Biotech Stocks With Potential
Seeking Alpha
Tue, 05/14/13 - 10:13 am
Keryx
NeoStem
ImmunoCellular Therapeutics
Sarepta
Sarepta's Meaningless Q1 Results
Motley Fool
Thu, 05/9/13 - 11:58 am
earnings
Sarepta
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Vertex Pharmaceuticals
Pharmacyclics
Novartis
Celsion
Peregrine Pharmaceuticals
Prana
Navidea Biopharmaceuticals
Cardinal Health
ONYX Pharmaceuticals
Bayer
Sarepta
Hyperion Therapeutics
Amarin
Medivation
Astellas
JNJ
Trius
Sangamo BioSciences
[video]3 Biggest Biotech Crashes in April
Motley Fool
Thu, 05/2/13 - 10:36 am
Dyax
Rigel Pharmaceuticals
Sarepta
AstraZeneca
Sarepta Therapeutics: Irrational Exuberance
Seeking Alpha
Thu, 04/25/13 - 09:24 am
Sarepta
GSK
eteplirsen
Duchenne Muscular Dystrophy
Quickly Approaching Biopharma Catalyst Events
Seeking Alpha
Wed, 04/24/13 - 10:27 am
Agenus
Aveo Pharmaceuticals
Insmed
GSK
Sarepta
FDA Says, "Call Me Maybe"
Motley Fool
Thu, 04/18/13 - 06:55 pm
FDA
Sarepta
eteplirsen
2 Views on Sarepta's FDA News
Motley Fool
Tue, 04/16/13 - 12:02 pm
FDA
Duchenne Muscular Dystrophy
Sarepta
eteplirsen
Sarepta tumbles after FDA requests more data on drug
The Fly on the Wall
Tue, 04/16/13 - 10:49 am
FDA
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Fans: A Single Data Slide Raises Questions About Glaxo's DMD Drug
TheStreet.com
Fri, 04/12/13 - 01:28 pm
Sarepta
GSK
Duchenne Muscular Dystrophy
drisapersen
eteplirsen
Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In
Seeking Alpha
Thu, 04/11/13 - 11:33 am
Duchenne Muscular Dystrophy
Sarepta
GSK
eteplirsen
drisapersen
Prosensa
Glaxo's Drisapersen Data Revealed Early
TheStreet.com
Tue, 04/9/13 - 04:02 pm
GSK
drisapersen
eteplirsen
Sarepta
Duchenne Muscular Dystrophy
Sarepta-Glaxo Duchenne's Rivalry Heats Up This Week
TheStreet.com
Mon, 04/8/13 - 11:27 am
GSK
Sarepta
Duchenne Muscular Dystrophy
drisapersen
Prosensa
eteplirsen
Sarepta's Eteplirsen Boys Keep On Walking
TheStreet.com
Fri, 04/5/13 - 10:45 am
Sarepta
Duchenne Muscular Dystrophy
eteplirsen
3 Small Cap Biopharmas Primed To Move Much Higher Now
Seeking Alpha
Wed, 03/27/13 - 12:27 pm
Acadia
Aveo Pharmaceutical
Sarepta
Sarepta set to rise if seeks quick drug OK
Reuters
Mon, 03/25/13 - 11:09 am
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
DB Analyst Gets It: Sarepta Is a Winner Even Without Accelerated Approval
TheStreet.com
Tue, 03/19/13 - 11:14 am
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tue, 03/12/13 - 11:45 am
Arena Pharmaceuticals
Sarepta
Ziopharm
Delcath
Aveo Pharmaceutical
United Therapeutics
AP Pharma
Titan Pharmaceuticals
Navidea Biopharmaceuticals
Biogen Idec
Raptor Pharmaceuticals
Investors Seeing Huge Potential In RNA Drug Developers
Seeking Alpha
Fri, 03/8/13 - 11:17 am
Sarepta
RXi Pharmaceuticals
OPKO
Alnylam
Pages
« first
‹ previous
1
2
3
4
next ›
last »